Zhao, Xiao, Li, Feng, Li, Yiye, Wang, Hai, Ren, He, Chen, Jing, Nie, Guangjun, Hao, Jihui (2022) Corrigendum to “Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer” [Biomaterials 46 (2015) 13–25]. Biomaterials, 280. 121296pp. doi:10.1016/j.biomaterials.2021.121296
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Corrigendum to “Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer” [Biomaterials 46 (2015) 13–25] | ||
Journal | Biomaterials | ||
Authors | Zhao, Xiao | Author | |
Li, Feng | Author | ||
Li, Yiye | Author | ||
Wang, Hai | Author | ||
Ren, He | Author | ||
Chen, Jing | Author | ||
Nie, Guangjun | Author | ||
Hao, Jihui | Author | ||
Year | 2022 (January) | Volume | 280 |
Publisher | Elsevier BV | ||
DOI | doi:10.1016/j.biomaterials.2021.121296Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 13895945 | Long-form Identifier | mindat:1:5:13895945:8 |
GUID | 0 | ||
Full Reference | Zhao, Xiao, Li, Feng, Li, Yiye, Wang, Hai, Ren, He, Chen, Jing, Nie, Guangjun, Hao, Jihui (2022) Corrigendum to “Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer” [Biomaterials 46 (2015) 13–25]. Biomaterials, 280. 121296pp. doi:10.1016/j.biomaterials.2021.121296 | ||
Plain Text | Zhao, Xiao, Li, Feng, Li, Yiye, Wang, Hai, Ren, He, Chen, Jing, Nie, Guangjun, Hao, Jihui (2022) Corrigendum to “Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer” [Biomaterials 46 (2015) 13–25]. Biomaterials, 280. 121296pp. doi:10.1016/j.biomaterials.2021.121296 | ||
In | (2022) Biomaterials Vol. 280. Elsevier BV |
See Also
These are possibly similar items as determined by title/reference text matching only.